EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lifestyle Behaviors and Cardiotoxic Treatment Risks in Adult Childhood Cancer Survivors

Ruijie Li iD, Raquel Revuelta Iniesta iD, Alan R Barker iD, Dimitris Vlachopoulos iD, Tomáš Sláma iD, Christina Schindera iD, Fabiën N Belle iD

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Ruijie Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Children's Health and Exercise Research Centre (CHERC), Public Health and Sport Sciences, Faculty of Health and Life Sciences, University of Exeter, …. Hauptthemen laut MEDLINE: Life Style, Cancer Survivors, Neoplasms, Cardiovascular Diseases. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Cancer Research, Stiftung für krebskranke Kinder-Regio Basiliensis, University of Basel, China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Higher doses of anthracyclines and heart‐relevant radiotherapy increase cardiovascular disease (CVD) risk. This study assessed CVD and CVD risk factors among adult childhood cancer survivors (CCSs) across cardiotoxic treatment risk groups and examined associations between lifestyle behaviors and treatment risks.

Methods

We invited CCSs aged ≥18 years at study, diagnosed at ages 0–20, who survived ≥5 years for an assessment of anthropometry, CVD, CVD risk factors, lifestyle, and cancer history. We classified participants into three cardiotoxic treatment risk groups (no/low risk, moderate risk, high risk) based on anthracyclines and heart‐relevant radiotherapy. Multinomial logistic regression assessed lifestyle differences across groups.

Results

With a median age at study of 33 years (IQR: 26–39; 53% male), 356 CCSs participated in this study divided into the no/low risk (25%), moderate risk (40%), or high risk (35%) cardiotoxic treatment groups. Overall, CVD prevalence was 6% and similar across the three risk groups. Heart valve problems were rare, though more common in the high‐risk group (no/low risk, 0%; moderate risk, 1%; vs. high risk, 4%; p = 0.037). CVD risk factors were present in 44% of CCSs—including dyslipidemia, obesity, hypertension, and diabetes—without variation across risk groups. Overall adherence to health behavior recommendations was low, with no differences in diet adherence, physical activity (PA), sedentary behavior, smoking, or alcohol consumption across cardiotoxic risk groups.

Conclusion

We found no differences in CVD, CVD risk factors, or lifestyle behaviors across cardiotoxic treatment risk groups. Health promotion that engages diet, PA, smoking cessation, and alcohol reduction should be prioritized for all CCSs regardless of cardiotoxic treatment risk levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Life StyleCancer SurvivorsNeoplasmsCardiovascular DiseasesCardiotoxicityAnthracyclinesRadiotherapyHumansFemaleMaleAdultYoung AdultChildAdolescentRisk FactorsFollow-Up StudiesInfantChild, PreschoolPrognosisInfant, Newborn

Stichwörter der Autor:innen

Switzerlandcardiovascular diseasediet adherencelate effectsphysical activity

Substanzen

Anthracyclines

Autor:innen und Institutionen

  • Children's Health and Exercise Research Centre (CHERC), Public Health and Sport Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
  • Childhood Cancer Research Group, Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
  • Division of Pediatric Oncology/Hematology, University Children's Hospital Basel, University of Basel, Basel, Switzerland.

ORCID-Profile: Ruijie Li, Raquel Revuelta Iniesta, Alan R Barker, Dimitris Vlachopoulos, Tomáš Sláma, Christina Schindera, Fabiën N Belle

Förderung

  • Swiss Cancer Research
  • Stiftung für krebskranke Kinder-Regio Basiliensis, University of Basel
  • China Scholarship Council
  • Swiss National Science Foundation
  • Swiss Cancer Research Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Li, R., Iniesta, R. R., Barker, A. R., Vlachopoulos, D., Sláma, T., Schindera, C., & Belle, F. N. (2026). Lifestyle Behaviors and Cardiotoxic Treatment Risks in Adult Childhood Cancer Survivors. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70089

Vancouver

Li R, Iniesta RR, Barker AR, Vlachopoulos D, Sláma T, Schindera C, et al. Lifestyle Behaviors and Cardiotoxic Treatment Risks in Adult Childhood Cancer Survivors. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70089

BibTeX
@article{Li2026,
  author = {Li, Ruijie and Iniesta, Raquel Revuelta and Barker, Alan R and Vlachopoulos, Dimitris and Sláma, Tomáš and Schindera, Christina and Belle, Fabiën N},
  title = {Lifestyle Behaviors and Cardiotoxic Treatment Risks in Adult Childhood Cancer Survivors},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70089}
}
Kostenlos starten →